F104S C-MPL Responds to a Transmembrane Domain−binding Thrombopoietin Receptor Agonist: Proof of Concept That Selected Receptor Mutations in Congenital Amegakaryocytic Thrombocytopenia Can Be Stimulated With Alternative Thrombopoietic Agents
Experimental Hematology - Netherlands
doi 10.1016/j.exphem.2010.02.007
Full Text
Open PDFAbstract
Available in full text
Date
May 1, 2010
Authors
Publisher
Elsevier BV